⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30536123 | 0.98 | — | — | |
| SCHEMBL7168808 | 0.77 | — | — | |
| SCHEMBL76303 | 0.64 | SUCNR1 (0.44) | — | |
| SCHEMBL25662212 | 0.64 | SUCNR1 (0.44) | — | |
| SCHEMBL25661131 | 0.64 | SUCNR1 (0.44) | — | |
| SCHEMBL25661135 | 0.64 | SUCNR1 (0.44) | — | |
| SCHEMBL11412447 | 0.64 | — | — | |
| SCHEMBL11459808 | 0.60 | SMN1; SMN2 (0.35) | — | |
| SCHEMBL25661144 | 0.60 | GABRR1 (0.36) | — | |
| SCHEMBL25661145 | 0.60 | GABRR1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024110366-A1 | A METHOD FOR CONTROLLING WEEDS | SYNGENTA CROP PROTECTION AG (CH) | 2024-05-30 | — | — | WO | claimed |
| CN-112920005-B | Preparation method of (R) -3- (3-chloro-2-fluorobenzene) -4, 5-dihydroisoxazole-5-carboxylic acid | 上海李氏化学科技有限公司 | 2022-06-14 | — | — | CN | claimed |
| US-12570675-B2 | Boronic acid compounds | LG CHEM, LTD. (KR) | 2026-03-10 | — | — | US | disclosed |
| WO-2025108865-A1 | HERBICIDAL COMPOSITIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2025-05-30 | — | — | WO | disclosed |
| CN-118843613-A | RXFP1 agonists | 百时美施贵宝公司 | 2024-10-25 | — | — | CN | disclosed |
| EP-4441035-A1 | PROCESS FOR PRODUCING ISOXAZOLINE-5,5-VINYLCARBOXYLIC ACID DERIVATIVES | Bayer Aktiengesellschaft (DE) | 2024-10-09 | — | — | EP | disclosed |
| EP-4422746-A1 | RXFP1 AGONISTS | Bristol-Myers Squibb Company (US) | 2024-09-04 | — | — | EP | disclosed |
| US-20240101579-A1 | BORONIC ACID COMPOUNDS | LG CHEM, LTD. (KR) | 2024-03-28 | — | — | US | disclosed |
| CN-117616014-A | Process for preparing isoxazoline carboxylic acid derivatives | 拜耳公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-111655686-B | Tetrahydroisoquinoline derivative and preparation method and application thereof | 四川科伦博泰生物医药股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| WO-2024013016-A1 | HERBICIDAL COMPOSITIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2024-01-18 | — | — | WO | disclosed |
| WO-2010036000-A2 | NOVEL OXAZOLIDINONE DERIVATIVES WITH CYCLIC AMIDOXIME OR CYCLIC AMIDRAZONE AND PHARMACEUTICAL COMPOSITIONS THEREOF | LEGOCHEM BIOSCIENCE LTD. (KR) | 2010-04-01 | — | — | WO | disclosed |
| WO-2010008775-A1 | AMINOPYRIDOPYRAZINONE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES | LIGAND PHARMACEUTICALS INC. (US) | 2010-01-21 | — | — | WO | disclosed |
| WO-2002000651-A2 | FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2002-01-03 | — | — | WO | disclosed |
| WO-2000033836-A9 | 5-MEMBERED HETEROCYCLES FOR THE TREATMENT OF HUMAN DISEASES INVOLVING MODULATORS OF SELECTINS | ONTOGEN CORP (US) | 2001-10-04 | — | — | WO | disclosed |
| CN-1251095-A | Lipase capalyzed dynamic resolution of isoxazoline thioester to isoxazoline carboxylic acids | PONT PHARMACEUTICAL CO DU (US) | 2000-04-19 | — | — | CN | disclosed |
| US-6022977-A | Dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids | DUPONT PHARMACEUTICALS COMPANY (US) | 2000-02-08 | — | — | US | disclosed |
| EP-0971906-A1 | LIPASE CATALYZED DYNAMIC RESOLUTION OF ISOXAZOLINE THIOESTERS TO ISOXAZOLINE CARBOXYLIC ACIDS | Du Pont Pharmaceuticals Company (US) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998042687-A1 | LIPASE CATALYZED DYNAMIC RESOLUTION OF ISOXAZOLINE THIOESTERS TO ISOXAZOLINE CARBOXYLIC ACIDS | DU PONT PHARMACEUTICALS COMPANY (US) | 1998-10-01 | — | — | WO | disclosed |
| WO-1996037492-A1 | ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-11-28 | — | — | WO | disclosed |